Filing Details
- Accession Number:
- 0001363763-15-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-31 16:21:52
- Reporting Period:
- 2015-08-28
- Filing Date:
- 2015-08-31
- Accepted Time:
- 2015-08-31 16:21:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
849636 | Cortex Pharmaceuticals Inc | CORX | Pharmaceutical Preparations (2834) | 330303583 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236365 | J S James Manuso | C/O Cortex Pharmaceuticals, Inc. 126 Valley Road, Suite C Glen Rock NJ 07452 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-28 | 11,887,779 | $0.00 | 11,887,779 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2015-08-28 | 23,775,558 | $0.00 | 23,775,558 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
23,775,558 | 2015-08-28 | 2020-09-30 | No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Options (to purchase shares of Common Stock) | $0.02 | 2025-08-18 | 5,081,300 | 5,081,300 | Direct | |
Common Stock | Common Stock Options (to purchase shares of Common Stock) | $0.02 | 2025-08-18 | 80,000,000 | 80,000,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2025-08-18 | 5,081,300 | 5,081,300 | Direct |
2025-08-18 | 80,000,000 | 80,000,000 | Direct |
Footnotes
- The reported securities are included within 11,887,779 units purchased by the reporting person for $0.02103 per unit. Each unit consists of one share of Common Stock and one warrant to purchase two additional shares of Common Stock with an exercise price of $0.02103 for each share of Common Stock to be issued upon exercise of the warrant.
- These Common Stock Options vest in three installments: 50 percent on August 18, 2015 (the grant date), 25 percent on February 18, 2016, and 25 percent on August 18, 2016.